Wegovy 0.25 mg Pen – Starter Dose

Description

Begin your weight loss journey with the Wegovy 0.25 mg Starter Pen, the first step in a medically supervised semaglutide-based treatment. This low-dose formulation is specially designed to help your body adjust to GLP-1 therapy, minimizing side effects such as nausea and bloating. As the entry point in the Wegovy titration schedule, it sets the foundation for effective and sustainable weight loss when combined with a reduced-calorie diet and increased physical activity.

💊 Key Features of Wegovy 0.25 mg

• Once-weekly injection for weight management

• Starter dose to minimize gastrointestinal side effects

• Contains semaglutide, a GLP-1 receptor agonist

• FDA-approved for chronic weight control

• May help reduce appetite and improve metabolic markers

📦 What’s Included

• 1 pre-filled pen delivering 0.25 mg of semaglutide per injection

• Patient instructions for proper injection technique

• Pen cap and safety guard

🌟 Benefits of the Starter Dose

• Allows your body to safely adapt to semaglutide

• Reduces chances of nausea, vomiting, and stomach upset

• Prepares you for the next dosing phase (0.5 mg)

• Begins supporting weight control and metabolic balance

• Ideal for first-time GLP-1 users

🩺 How to Use

• Inject subcutaneously once per week, on the same day

• Use a new needle for each injection

• Inject into the abdomen, thigh, or upper arm—rotate sites weekly

• Use all 4 doses over a 28-day period before moving to the next dose level

⚠️ Safety Information / Warnings

• For adults with obesity (BMI ≥30) or overweight (BMI ≥27 with weight-related conditions)

• Not for patients with Type 1 diabetes, pancreatitis, or a history of medullary thyroid carcinoma

• Common side effects: nausea, diarrhea, constipation, fatigue, bloating, headache

• Do not use multiple pens at once or accelerate your titration schedule

• Discuss with your provider if taking insulin or other glucose-lowering medications

❄️ Storage & Handling

• Store unopened pens in the refrigerator: 2°C to 8°C (36°F to 46°F)

• After opening, the pen can be stored at room temperature (up to 30°C / 86°F) for up to 28 days

• Do not freeze. Discard if the pen has been frozen or exposed to excessive heat

• Keep away from direct sunlight and moisture

❓ Frequently Asked Questions

Q: Do I need to stay on the 0.25 mg dose?
A: No. The 0.25 mg dose is intended for the first 4 weeks only. After that, you’ll increase to the 0.5 mg pen, unless otherwise directed by your healthcare provider.

Q: What happens if I miss a dose?
A: If it’s been fewer than 5 days since your missed dose, take it as soon as you remember. If more than 5 days have passed, skip the dose and take the next one on your usual day. Do not double up.

Q: Is weight loss expected on the 0.25 mg dose?
A: Some patients experience early appetite reduction, but significant weight loss usually begins at higher doses later in the program.

Q: Can I use this if I’m not diabetic?
A: Yes. Wegovy is FDA-approved for chronic weight management, not just for diabetic patients. It’s commonly prescribed for non-diabetic individuals who meet the BMI criteria.

Q: Will Wegovy lower blood pressure?
A: Yes, Wegovy (semaglutide) can lower blood pressure, both in individuals with and without pre-existing hypertension. It’s been shown to reduce the risk of cardiovascular events like heart attacks and strokes, in part by lowering blood pressure. This effect is seen even in individuals with normal blood sugar levels, suggesting it’s not solely due to weight loss.

Q: Is Wegovy the same as Rybelsus?
A: Rybelsus and Wegovy are two medications that contain semaglutide. But Rybelsus is an oral pill that you take every day and Wegovy is a once-weekly injection. Rybelsus is only approved to treat Type 2 diabetes in adults.

Q: Where is Wegovy being made?
A: Wegovy is manufactured by Novo Nordisk, a Danish pharmaceutical company. While the exact production locations are not publicly detailed, Novo Nordisk has facilities in several countries, including Denmark, the US, and France, according to their official website. Wegovy is a brand name for the medication semaglutide, which is used for chronic weight management.